[Susceptibility of bacteria isolated from clinical material to ciprofloxacin]. 1995

E Namysł, and J Galiński, and M Szponar, and L Piechowicz
Katedra i Zakład Mikrobiologii Lekarskiej Akademii Medycznej w Gdańsku.

The aim of the study was to evaluate susceptibility to ciprofloxacin of bacteria species isolated from different specimens of clinical materials. The investigated strains (830) were identified using conventional methods. The antibacterial activity of ciprofloxacin was studied by the method of drug dilution in Mueller-Hinton agar. Among aerobic bacteria, only 5 strains (0.6%) were resistant to ciprofloxacin in concentration 4 micrograms/ml; two belonged to E. coli species, two to S. aureus and one was a Streptococcus group B., Corynebacterium sp. MIC90 = 0.12 microgram/ml turned out to be most resistant, next, Gram-negative rods MIC90 = 0.5 microgram/ml, coagulase-negative and positive staphylococci and Neisseria sp. MIC90 = 1.0 microgram/ml. Enterococcus faecalis and anaerobes were the least susceptible to ciprofloxacin. Their MIC90 was 2 and 16 micrograms/ml respectively. Among 20 anaerobic strains, up to 10 were resistant to ciprofloxacin, mainly from Bacteroides and Clostridium genus.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D001420 Bacteria, Aerobic Bacteria which require oxygen in order to grow and survive. Aerobic Bacteria
D001421 Bacteria, Anaerobic Bacteria that can survive and grow in the complete, or nearly complete absence of oxygen. Anaerobic Bacteria
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

E Namysł, and J Galiński, and M Szponar, and L Piechowicz
January 1993, Medycyna doswiadczalna i mikrobiologia,
E Namysł, and J Galiński, and M Szponar, and L Piechowicz
August 1971, Rinsho byori. The Japanese journal of clinical pathology,
E Namysł, and J Galiński, and M Szponar, and L Piechowicz
December 1990, The Journal of antimicrobial chemotherapy,
E Namysł, and J Galiński, and M Szponar, and L Piechowicz
October 1987, Mikrobiyoloji bulteni,
E Namysł, and J Galiński, and M Szponar, and L Piechowicz
January 1996, European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery,
E Namysł, and J Galiński, and M Szponar, and L Piechowicz
August 1971, Rinsho byori. The Japanese journal of clinical pathology,
E Namysł, and J Galiński, and M Szponar, and L Piechowicz
April 2010, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology],
E Namysł, and J Galiński, and M Szponar, and L Piechowicz
September 1969, Applied microbiology,
E Namysł, and J Galiński, and M Szponar, and L Piechowicz
February 2009, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering,
E Namysł, and J Galiński, and M Szponar, and L Piechowicz
February 1972, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!